drugset / Trial / NCT02965703
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
RandomizedParallel-groupDouble-blindPrevention
Summary
This phase IIa trial studies how well aspirin works in preventing colorectal cancer in patients with colorectal adenoma. Aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2018-01-16
- Primary completion
- 2023-01-31
- Completion
- 2026-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 325 mg | Oral |